Severe combined immune deficiency due to a homozygous 3.2-kb deletion spanning the promoter and first exon of the adenosine deaminase gene

Nucleic Acids Res. 1987 Nov 25;15(22):9365-78. doi: 10.1093/nar/15.22.9365.

Abstract

We have investigated the structural gene for adenosine deaminase (ADA) in a female infant with ADA deficiency associated severe combined immune deficiency (ADA-SCID) disease and her family by DNA restriction-fragment-length analysis. In this family a new ADA-specific restriction-fragment-length variant was detected, which involves a 3.2-kb deletion spanning the ADA promoter as well as the first exon. It was found that the patient, who was born to a consanguineous couple, was homozygous and both her parents and her brother were heterozygous for the deletion. No ADA-specific mRNA could be detected by hybridization in fibroblasts derived from this patient. Thus the patient was established to be homozygous for a true null ADA allele. In the light of the apparently normal development of most tissues except the lymphoid tissue the above finding directly questions the classification of ADA as a 'housekeeping' enzyme.

Publication types

  • Case Reports
  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Deaminase / blood
  • Adenosine Deaminase / deficiency*
  • Chromosome Deletion*
  • Erythrocytes / enzymology
  • Exons*
  • Female
  • Genes*
  • Homozygote*
  • Humans
  • Immunologic Deficiency Syndromes / enzymology
  • Immunologic Deficiency Syndromes / genetics*
  • Infant
  • Leukocytes / enzymology
  • Male
  • Nucleoside Deaminases / deficiency*
  • Promoter Regions, Genetic*
  • RNA, Messenger / genetics
  • Reference Values
  • Transcription, Genetic

Substances

  • RNA, Messenger
  • Nucleoside Deaminases
  • Adenosine Deaminase